文献速递心律失常

瑞典十年心律失常导管消融:消融实践与结局

A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes.
PubMed 文献 · Eur Heart J · 2019-01-01

消融谱随时间向心房颤动、室性心动过速和室性早搏倾斜,手术时间和透视时间均下降,房颤3年内重复消融率最高达41%,报告的不良事件率为1.7%。

要点

  • 房颤消融占比最高(35%),且房颤、室速和室早消融逐年增加。
  • 所有心律失常类型的消融手术时间和透视时间均随时间下降。
  • 房颤3年内重复消融率最高(41%),报告不良事件率低(1.7%)。

核心结论

  • 过去十年导管消融向更复杂手术转变,透视时间显著减少,房颤消融疗效似乎改善。

研究设计与样本

  • 基于瑞典全国注册数据的回顾性队列研究,纳入2006年1月1日至2015年12月31日连续≥18岁接受导管消融的患者,随访至2016年12月31日。

主要发现

  • 房颤、室速和室早消融随时间逐渐增加(P < 0.001)。
  • 所有心律失常类型的消融手术时间和透视使用均随时间下降。
  • 重复消融率因消融类型而异,房颤3年内重复消融率最高(41%)。
  • 报告的不良事件率低(n=595,1.7%),消融后近期死亡罕见(n=116,0.34%)。

临床怎么用

  • 真实世界数据支持导管消融在多种快速性心律失常中的应用,尤其是房颤消融比例增加且疗效改善。
  • 需关注房颤消融后较高的重复消融率,合理规划随访和患者选择。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Catheter ablation is considered the treatment of choice for many tachyarrhythmias, but convincing 'real-world' data on efficacy and safety are lacking. Using Swedish national registry data, the ablation spectrum, procedural characteristics, as well as ablation efficacy and reported adverse events are reported. METHODS AND RESULTS: Consecutive patients (≥18 years of age) undergoing catheter ablation in Sweden between 01 January 2006 and 31 December 2015 were included in the study. Follow-up (repeat ablation and vital status) was collected through 31 December 2016. A total of 26 642 patients (57 ± 15 years, 62% men), undergoing a total of 34 428 ablation procedures were included in the study. In total, 4034 accessory pathway/Wolff-Parkinson-White syndrome (12%), 7358 AV-nodal re-entrant tachycardia (21%), 1813 atrial tachycardia (5.2%), 5481 typical atrial flutter (16%), 11 916 atrial fibrillation (AF, 35%), 2415 AV-nodal (7.0%), 581 premature ventricular contraction (PVC, 1.7%), and 964 ventricular tachycardia (VT) ablations (2.8%) were performed. Median follow-up time was 4.7 years (interquartile range 2.7-7.0). The spectrum of treated arrhythmias changed over time, with a gradual increase in AF, VT, and PVC ablation (P < 0.001). Decreasing procedural times and utilization of fluoroscopy with time, were seen for all arrhythmia types. The rates of repeat ablation differed between ablation types, with the highest repeat ablation seen in AF (41% within 3 years). The rate of reported adverse events was low (n = 595, 1.7%). Death in the immediate period following ablation was rare (n = 116, 0.34%). CONCLUSION: Catheter ablations have shifted towards more complex procedures over the past decade. Fluoroscopy time has markedly decreased and the efficacy of catheter ablation seems to improve for AF.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Holmqvist F, Kesek M, Englund A, et al. A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. Eur Heart J. 2019. PMID: 30452631. doi:10.1093/eurheartj/ehy709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。